Curagen (CRGN) Inactive 10-Q2005 Q3 Quarterly report

Filed: 4 Nov 05, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: addressed, area, assembly, begun, carboplatin, cGMP, chain, chemotherapeutic, created, currency, de, diplomatic, disaster, distributor, encounter, entail, exact, export, faster, foregoing, formula, fraction, geopolitical, harbor, instability, internationally, mapping, mesangial, mission, novo, obsolescence, ovarian, PA, paclitaxel, Philadelphia, political, presence, processed, proposed, Reform, Renal, Rule, Science, SEC, shotgun, social, software, Solexa, solution, straight, summarized, supplier, understand, underwent, underwriting, unexpected, valuation, version, Week, worldwide

Removed: accessed, agriculture, arrest, biodefense, cell, database, death, designation, differentiation, fee, implement, induce, industrial, inhibit, initiating, Internet, investigate, iv, ix, largely, library, mechanistic, monitoring, nanoscale, NCI, orphan, overcome, parallel, poster, programmed, promote, proven, registration, remained, resistance, scaling, sensitize, sponsor, undergoing, untested, vi, vii, viii, volume, widespread, xi, xii, xiii, xiv, xix, xv, xvi, xvii, xviii, xx, xxi, xxii, xxiii, xxiv, xxv, xxvi

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

CRGN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of CuraGen Corporation, a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report on Form 10-Q for the period ended September 30, 2005 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated: November 4, 2005	By:	/s/ PATRICK J. ZENNER
		Patrick J. Zenner
		Interim Chief Executive Officer and Chairman of the Board (principal executive officer of the registrant)

Dated: November 4, 2005	By:	/s/ DAVID M. WURZER
		David M. Wurzer
		Executive Vice-President, Chief Financial Officer and Treasurer (principal financial and accounting officer of the registrant)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.